Multiple sclerosis progression: time for a new mechanism-driven frameworkTanja Kuhlmann, Emmaunelle Waubant, Marcello Moccia et al.|The Lancet Neurology|2022Cited by 624
Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysisAxel Petzold, Bernhard Hemmer, Laura J. Balcer et al.|The Lancet Neurology|2017Cited by 572
Adherence and Satisfaction of Smartphone- and Smartwatch-Based Remote Active Testing and Passive Monitoring in People With Multiple Sclerosis: Nonrandomized Interventional Feasibility StudyLuciana Midaglia, Michael Lindemann, Patricia Mulero et al.|Journal of Medical Internet Research|2019Cited by 141
A smartphone sensor-based digital outcome assessment of multiple sclerosisXavier Montalbán, Stephen L. Hauser, Jennifer Graves et al.|Multiple Sclerosis Journal|2021Cited by 112
Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trialBruce Cree, Piotr Sokolowski, Gary Cutter et al.|The Lancet Neurology|2020Cited by 104